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Body mass index (BMI) has been identified as an important modifiable lifestyle risk factor for dementia, but less 
is known about how BMI might interact with Apolipoprotein E ɛ4 (APOE ɛ4) carrier status to predict conversion 
to mild cognitive impairment (MCI) and dementia. 
Objective: 
The aim of this study was to investigate the interaction between APOE ɛ4 status and baseline (bBMI) and five-
year BMI change (ΔBMI) on conversion to MCI or dementia in initially cognitively healthy older adults. 
Methods: 
The associations between bBMI, ΔBMI, APOE ɛ4 status, and conversion to MCI or dementia were investigated 
among 1,289 cognitively healthy elders from the National Alzheimer’s Coordinating Center (NACC) database. 
Results: 
After five years, significantly more carriers (30.6%) converted to MCI or dementia than noncarriers 
(17.6%), p < 0.001, OR = 2.06. Neither bBMI (OR = 0.99, 95%CI = 0.96–1.02) nor the bBMI by APOE interaction 
(OR = 1.02, 95%CI = 0.96–1.08) predicted conversion. Although ΔBMI also did not significantly predict conversion 
(OR = 0.90, 95%CI = 0.78–1.04), the interaction between ΔBMI and carrier status was significant (OR = 0.72, 
95%CI = 0.53–0.98). For carriers only, each one-unit decline in BMI over five years was associated with a 
27%increase in the odds of conversion (OR = 0.73, 95%CI = 0.57–0.94). 
Conclusion: 
A decline in BMI over five years, but not bBMI, was strongly associated with conversion to MCI or dementia only 
for APOE ɛ4 carriers. Interventions and behaviors aimed at maintaining body mass may be important for long 
term cognitive health in older adults at genetic risk for AD. 
INTRODUCTION 
The Apolipoprotein E ɛ4 (APOE ɛ4) allele is an important genetic risk factor for late onset Alzhei-mer’s disease 
(AD). Having one ɛ4 allele triples one’s risk of developing AD and having two ɛ4 alleles is associated with a 12 
times greater risk of AD compared to those with no ɛ4 allele [1, 2]. Yet not all carriers develop AD during their 
lifespan, with nearly 50%of homozygous APOE ɛ4 carriers aged 80 or older never developing AD [3]. Potentially 
modifiable factors, such as physical activity, may influence whether a cognitively intact carrier develops mild 
cognitive impairment (MCI) or AD [4–7]. Obesity is another modifiable lifestyle factor, but it is unclear whether 
body mass is a significant predictor of conversion from cognitively intact to MCI/AD. 
Results of studies examining the relationship between body mass or weight in healthy individuals and the future 
risk of developing dementia are contradictory. Several studies have shown that increased body mass index (BMI) 
in midlife raises the risk of developing dementia [8–15]. In a sample of 8,534 twins, being overweight or obese in 
midlife was associated with an increased risk of dementia, AD, and vascular dementia [14]. In addition, this 
relationship was attenuated in dementia-discordant twin pairs, indicating that genetic and family environmental 
factors may contribute to the relationship between high BMI and dementia. Another study found that each unit 
increase in BMI during midlife predicted an earlier onset of AD by 6.7 months, suggesting that maintaining a 
healthy BMI in midlife may delay the onset of AD [16]. Paradoxically, other reports suggest that a low BMI 
(< 20 kg/m2) in late-life increases the risk of MCI or dementia, whereas high BMI (> 30 kg/m2) reduces the risk [10, 
17–19]. In a sample of 6,940 older adults from the National Alzheimer’s Coordinating Center Uniform Data Set, 
higher late-life baseline BMI was associated with a reduced risk of conversion to MCI over a mean 3.8-year 
period (OR = 0.977), but higher BMI was no longer protective when rapid weight loss was present [20]. Other 
studies have shown that a decline in BMI during mid-life increases the risk of AD in late-life [9, 21–27]. Finally, 
others have shown that both weight gain and weight loss are associated with incidence of dementia [28]. 
Overall, these results demonstrate that the relationship between BMI and dementia risk is complicated and 
dependent on age, with higher BMI increasing risk of dementia in midlife while being apparently protective in 
late life [29]. Maintaining a stable BMI throughout midlife and late life appears to be associated with a reduced 
risk of dementia. 
Whereas a number of studies have examined the relationship between BMI and risk of conversion to dementia, 
there has been little examination into the role of APOE genotype as a potential moderator variable. One pilot 
study analyzed a sample of 153 older adults with late-onset Alzheimer’s disease (LOAD; mean age 78.2 years) 
and 302 control subjects (mean age 87.2 years) to determine various gene/gene and gene/environment 
relationships that predict AD [30]. They found that APOE ɛ4 carriers (but not noncarriers) with LOAD were more 
likely to have been obese at age 50. Other studies have shown that lower BMI in old age is associated with 
poorer cognition in APOE ɛ4 carriers only. In a longitudinal study that followed older adults aged 65 and older 
for over 10 years, BMI and APOE ɛ4 carrier status interacted to predict cognitive impairment, with lower BMI 
predicting greater cognitive impairment for carriers only [31]. Another study reported that in elder APOE ɛ4 
carriers only, a lower BMI was associated with greater cognitive decline, whereas obesity was associated with 
improved cognitive performance and slower progression of cognitive decline [32]. Conversely, other studies 
have found no APOE ɛ4 x BMI interaction on dementia risk [11, 33]. In a sample of 1,890 Japanese American 
men followed longitudinally for 32 years, those who developed dementia had greater weight loss in the six years 
prior to diagnosis than those who did not develop dementia [34]. The APOE ɛ4 allele did not modify this 
relationship, but there was a trend toward the rate of weight change being weaker in AD patients who 
were APOE ɛ4 carriers. Therefore, the literature on this topic is still inconclusive, with some studies revealing 
that the relationship between measures of adiposity and cognitive decline in old age is stronger in APOE ɛ4 
carriers than in noncarriers and others suggesting no relationship at all. To our knowledge, no study has 
examined how APOE ɛ4 carrier status and change in BMI interact to predict conversion to MCI or dementia in a 
sample of cognitively healthy elders. 
APOE ɛ4 is a risk factor for cardiovascular and metabolic disease, and results in poor handling of cholesterol and 
compromised glucose metabolism, in addition to being associated with a reduced capacity to clear brain amyloid 
[35, 36]. Thus, it is reasonable to hypothesize that APOE genotype and other metabolic processes that lead to 
increased body mass may interact and exacerbate cognitive decline. The purpose of the current study was to 
further examine the relationship between BMI and conversion to dementia by examining the possible 
moderating roles of the APOE ɛ4 allele using data from the National Alzheimer’s Coordinating Center (NACC) 
Uniform Data Set (UDS). Specifically, we examined whether baseline BMI in healthy elders predicts conversion to 
MCI over a five-year follow-up interval differentially in APOE carriers and noncarriers. We also examined 
whether changes in BMI over the five-year interval were associated with conversion and carrier status. 
METHODS 
Setting and participants 
This report is based on analyses from 36 Alzhei-mer’s Disease Research Centers (ADRCs) for UDS visits 
conducted between September 2005 and March 2019. For a complete description of data and procedures, refer 
to Beekly et al. (2007) and Besser et al. (2018) [37, 38]. The sample was restricted to 1,289 individuals who were 
specifically recruited to be cognitively intact at initial visit (see Fig. 1 for selection and exclusion details). 
Participants included 386 heterozygous APOE ɛ4 carriers (ɛ3/ɛ4) and 903 noncarriers (ɛ3/ɛ3) who were 65 to 80 
years of age at baseline (M = 72.1, SD = 4.5) with a valid BMI assessed at baseline and five-year follow-up within 
the range of 10 to 100 (M = 27.1, SD = 5.1). Homozygous carriers (ɛ4/ɛ4; N = 44) and those containing the 
protective ɛ2 allele (N = 234) were excluded from analyses. There were 1,085 (84.2%) white and 204 (15.8%) 
nonwhite individuals in the overall sample. The sample included participants who either remained cognitively 
normal or proceeded to develop MCI or AD (primary, contributing, or non-contributing) within 4.8 to 5.7 years 
(M = 5.2, SD = 0.2), representing the 25th to 75th percentiles of all follow-ups approximating five years. 
Individuals who reverted at any visit from MCI to cognitively normal or from AD to either MCI or cognitively 
normal were excluded from analyses. Furthermore, 17 participants were removed from all analyses as outliers 
on at least two of the following three criteria, as measured by influence plots: hat-values, Cook’s distance, and 
studentized residuals. All participants performed within age- and sex-appropriate limits at initial visit. All 
participants provided written informed consent and were financially compensated for participation. Because of 
missing data on various measures, the sample size for specific analyses varied slightly from the maximum of 
1,289 (see Table 1). 
Fig. 1. Consort Diagram Displaying Derivation of Study Sample for Analysis with Source of Exclusion. 
 
 
Table 1. Group Differences in BMI (Baseline and Five-year Change) and Demographics as a Function of APOE ɛ4 Carrier Status and Conversion to MCI or 
Dementia 




     
 
ɛ4-  ɛ4+  Conversion  APOE  Interaction  
Variable Converters Nonconverters Converters Nonconverters p ES p ES p ES 
N (Total = 1289) 159 744 118 268 
      
Age, M (SD) 74.3 (4.0) 72.0 (4.5) 73.1 (4.3) 70.8 (4.2) < 0.001 –0.528a < 0.001 0.269a 0.937 < 0.001b 
Education, M 
(SD) 
15.8 (3.1) 16.2 (3.0) 16.2 (2.9) 15.9 (2.9) 0.811 0.017a 0.636 0.033a 0.121 0.002b 
Sex, N (%Male) 66 (41.5) 246 (33.1) 43 (36.4) 88 (32.8) 0.049 0.003c 0.832 < 0.001c - - 
Race, N 
(%White) 
145 (91.2) 620 (83.3) 104 (88.1) 216 (80.6) 0.003 0.007c 0.413 < 0.001c - - 
Baseline BMI 
(kg/m2), M (SD) 
26.6 (4.9) 27.3 (5.2) 26.8 (4.9) 27.1 (5.0) 0.335 0.069a 0.974 0.002a 0.392 < 0.001b 
ΔBMI, M (SD) –0.03 (1.0) 0.007 (1.0) –0.3 (1.2) 0.1 (0.9) 0.066 0.136a 0.168 0.101a 0.034d 0.004b 
ΔBMI, five-year age- and education-adjusted standardized residualized change (z-score units); Baseline BMI adjusted for age and education; ES, effect 
size: aCohen’s d, bpartial eta2, and cphi2. dFollow-up Games-Howell analyses of simple effects showed the interaction was due to a greater decline in BMI 
for carriers who converted to MCI/AD versus carriers who did not convert, p = 0.006, d = 0.34 rather than for noncarriers who converted versus 
noncarriers who did not convert, p = 0.65, d = 0.02. 
Body mass index 
Baseline BMI (bBMI) was calculated using first visit height (m) and weight (kg) and coded as a continuous 
measure (kg/m2). BMI at visit 6, approximately five years from baseline, was also calculated as a continuous 
measure (kg/m2) from visit height (m) and weight (kg) at that timepoint. 
Statistical analysis 
Demographic information grouped by APOE ɛ4 status and conversion status is displayed in Table 1. Five-year 
change in BMI (ΔBMI) was calculated using standardized residual change scores (z-score units; see Table 1). 
Pearson χ2 tests were used to identify associations between conversion status and APOE ɛ4 carrier status. 
Cochran-Mantel-Haenszel (CMH) homogeneity tests were used to evaluate the possibility that sex or race (white 
versus nonwhite) may be confounders of this relationship. In addition, two-way factorial analyses of covariance 
(ANCOVA) investigated the main and interactive effects of conversion and APOE carrier status on age- and 
education-adjusted bBMI and ΔBMI. Any significant interaction was followed up with analysis of simple effects 
using Games-Howell post hoc comparisons due to unequal sample sizes and slight heterogeneity of variance 
across groups, whereby converters and nonconverters were compared separately for carrier and noncarrier 
groups. Last, a sequential logistic regression analysis was performed to assess prediction of conversion, first on 
the basis of bBMI, APOE ɛ4 status, and four demographic predictors and then after addition of the bBMI 
x APOE interaction term. Demographic predictors were age, sex, education, and race. A second sequential 
logistic regression repeated the previously described model, replacing bBMI with ΔBMI. 
RESULTS 
Sample characteristics 
At approximately five years follow-up, substantially more carriers (30.6%) converted to MCI or dementia than 
noncarriers (17.6%), χ2 (1) = 26.9, p < 0.001, Crude OR = 2.06 (see Table 1). CMH tests of homogeneity suggested 
that neither race (nonwhite OR = 2.38, white OR = 2.06, CMH combined OR = 2.09, χ2 (1) = 0.11, p = 0.738) nor sex 
(male OR = 1.82, female OR = 2.23, CMH combined OR = 2.07, χ2 (1) = 0.48, p = 0.488) modified this 
association. Table 1 also shows that the proportion of males in each carrier group was comparable (ɛ4 
noncarriers: n = 312 [34.6%]; ɛ4 carriers: n = 131 [33.9%]; φ2 < 0.001, p = 0.83), but there was a slightly larger 
proportion of men in the converter group (nonconverters: n = 334 [33.0%]; converters: n = 109 
[39.4%]; φ2 = 0.003, p = 0.049). There were proportionally more white individuals (n = 249 [22.9%]) in the 
converter group than nonwhites (n = 28 [13.7%]), φ2 = 0.007, p = 0.003). Carrier groups did not differ in their 
respective proportions of white individuals (ɛ4 noncarriers: n = 765 [84.7%]; ɛ4 carriers: n = 320 
[82.9%]; φ2 < 0.001, p = 0.41). Two-way factorial ANOVAs on age revealed main effects of conversion group and 
carrier status but no interaction effect, such that converters (M = 73.8 years, SD = 4.2 years) were significantly 
older on average than nonconverters (M = 71.7 years, SD = 4.5 years) at baseline, and noncarriers (M = 72.4 
years, SD = 4.5 years) were significantly older than carriers (M = 71.5 years, SD = 4.4 years). No main or interaction 
effects for conversion or carrier status were observed for number of years of education or for age- and 
education-adjusted bBMI. 
When examining age- and education-adjusted ΔBMI, there were no main effects of conversion status, F(1, 
1207) = 3.38, p = 0.066, or carrier status, F(1, 1207) = 1.91, p = 0.168. However, the interaction between 
conversion and carrier status on ΔBMI was significant, F(1, 1207) = 4.48, p = 0.034 (see Fig. 2). Games-Howell 
analyses of simple effects revealed that this interaction was driven by a significantly greater decline in BMI for 
carriers who converted to MCI or dementia (M = –0.26, SD = 1.2) than for carriers who did not convert 
(M = 0.10, SD = 0.9), p = 0.006, d = 0.34. There was no significant difference in ΔBMI between non-carriers who 
converted (M = –0.03, SD = 1.0) and who did not convert (M = 0.01, SD = 1.0), p = 0.646, d = 0.018. 
Fig. 2. Change in BMI as a Function of Conversion to MCI or Dementia (Top) and Both Conversion and APOE ɛ4 
Carrier Status (Bottom). Change in BMI represents the mean five-year standardized residualized change (z-score 
units) for each group. Numbers on x-axes represent sample size within each group. 
 
APOE ɛ4 and baseline BMI predicting conversion 
A sequential logistic regression analysis assessed whether carrier status, bBMI, and their interaction predict 
conversion to MCI or dementia after controlling for age, sex, race, and education. Table 2 shows the results of a 
hierarchical binary logistic regression, where APOE ɛ4 status, bBMI, age, sex, race, and education were entered 
simultaneously into the first model and the interaction between carrier status and bBMI was added to the 
second model (only model 2 is displayed). As expected, APOE ɛ4 carrier status was a statistically significant 
predictor of conversion (OR = 2.43, SE = 0.15, p < 0.001), suggesting that the odds of conversion for APOE ɛ4 
carriers was 2.4 times greater than for non-carriers. Race significantly predicted conversion as well 
(OR = 1.89, SE = 0.23, p = 0.006), indicating that the odds of conversion for white participants was 1.9 times 
greater than for nonwhite participants. Age was also a significant predictor (OR =1.13, SE = 0.02, p < 0.001), 
indicating that each one-year increase in age raised the odds of conversion by 13%. bBMI did not significantly 
predict conversion status (OR = 0.99, SE = 0.02, p = 0.48), nor did sex (OR = 1.26, SE = 0.15, p = 0.12) or education 
(OR = 0.97, SE = 0.03, p = 0.22). The interaction between APOE ɛ4 carrier status and bBMI, controlling for the 
previously entered demographic variables, was also non-significant in model 2 (OR =1.02, SE = 0.03, p = 0.60). 
Table 2. Logistic Regression with APOE ɛ4 Carrier Status, Bmi (Baseline And Five-Year Change), Age, Sex, Education, and Race Predicting Conversion to 
MCI or Dementia 




Model 1 - Baseline BMI (bBMI) (Intercept) –9.82 1.44 46.45 1 < 0.001 < 0.001 
  
  APOE 0.89 0.15 35.93 1 < 0.001 2.44 1.82–3.26 
 
  Age 0.12 0.02 51.40 1 < 0.001 1.12 1.09–1.16 
 
  Sex 0.23 0.15 2.45 1 0.12 1.26 0.94–1.70 
 
  Education –0.03 0.03 1.49 1 0.22 0.97 0.93–1.02 
 
  Race 0.64 0.23 7.66 1 0.006 1.90 1.21–2.99 
 
  bBMI –0.02 0.02 0.83 1 0.36 0.98 0.95–1.02 
 
  APOE * bBMI 0.02 0.03 0.33 1 0.56 1.02 0.96–1.08 
 
        
0.112 
Model 2 - Five-Year Standardized Residual Change in BMI (ΔBMI) 
(Intercept) 
–10.04 1.35 55.71 1 < 0.001 < 0.001 
  
  APOE 0.85 0.16 29.25 1 < 0.001 2.33 1.72–3.17 
 
  Age 0.11 0.02 42.12 1 < 0.001 1.12 1.08–1.16 
 
  Sex 0.29 0.16 3.41 1 0.065 1.33 0.98–1.80 
 
  Education –0.02 0.03 0.59 1 0.44 0.98 0.93–1.03 
 
  Race 0.66 0.24 7.83 1 0.005 1.93 1.22–3.07 
 
  ΔBMI 0.01 0.09 0.01 1 0.92 1.01 0.84–1.21 
 
  APOE * ΔBMI –0.33 0.16 4.47 1 0.035 0.72 0.53–0.98 
 
        
0.113 
Sex: males = 1, females = 0; Race: white = 1, nonwhite = 0; APOE: carrier = 1, noncarrier = 0. 
APOE ɛ4 and change in BMI predicting conversion 
A second logistic regression analysis repeated the previous analysis with ΔBMI replacing bBMI in the 
model. Table 2 displays the results of the second hierarchical binary logistic regression, where APOE ɛ4 
status, ΔBMI, age, sex, race, and education were entered simultaneously into the first model and the interaction 
between carrier status and ΔBMI was added to the second model (only model 2 is displayed). Again, APOE ɛ4 
status was a statistically significant predictor of conversion (OR = 2.40, SE = 0.15, p < 0.001), indicating that the 
odds of conversion to MCI or dementia are 140%greater for carriers than for noncarriers. Race remained a 
significant predictor of conversion as well (OR = 1.93, SE = 0.24, p = 0.005), signifying that being white (versus 
nonwhite) increased the odds of converting by 93%. Age also remained a significant predictor 
(OR = 1.12, SE = 0.02, p < 0.001), indicating that a one-year increase in age raised the odds of conversion by 
12%. ΔBMI did not significantly predict conversion (OR = 0.90, SE = 0.07, p = 0.14), nor did sex 
(OR = 1.33, SE = 0.15, p = 0.063) or education (OR = 0.98, SE = 0.03, p = 0.44). However, the interaction 
between ΔBMI and carrier status was significant in the second model, OR = 0.72, SE = 0.16, p = 0.035. To further 
interpret the interaction, an additional logistic regression assessed the effects of ΔBMI on conversion separately 
for carriers and noncarriers, while controlling for age, sex, education, and race in the model. All predictors were 
entered simultaneously. ΔBMI was a significant predictor of conversion for carriers only 
(OR = 0.73, SE = 0.13, p = 0.013), such that greater declines in BMI over the five-year period were associated with 
an increased likelihood of conversion. This relationship was not observed in noncarriers 
(OR = 1.00, SE = 0.094, p = 0.98). 
DISCUSSION 
In our study, a decline in BMI over a five-year period, but not baseline BMI, predicted conversion to MCI or 
dementia uniquely in APOE ɛ4 carriers. Thus, the results of our study suggest that risk of conversion to MCI or 
dementia may be greatest among APOE ɛ4 carriers who experience significant declines in BMI. 
Weight loss has been associated with cognitive impairment and greater dementia risk across the age spectrum, 
but notably the investigation of the role of APOE as a potential moderator of this risk has been absent. One 
study examined the association of change in BMI and risk of AD in 918 healthy older adults [21]. They found that 
losing one unit of BMI per year led to a 25%greater risk of AD compared to those with no change in BMI. 
Similarly, others have found that every one-unit decrease in BMI over a 26-year period from midlife to late-life 
was associated with a 20%greater risk of AD [22]. Additionally, a > 10%loss in BMI over a 3-year period has been 
associated with increased risk of dementia, whereas gains in BMI were not [39]. Other studies have found that 
both weight gain and loss are associated with greater risk of AD, with one recent study finding that rapid weight 
change characterized by greater than 10%loss or gain in BMI over two years increased risk of dementia by 
20%compared to persons with a stable BMI [28]. For our study and others that did not find such an effect with 
weight gain, it is possible that the effect of weight loss on AD risk is simply greater and categorizing individuals 
into groups based on percent change in BMI with adequate sample sizes in each group is necessary to detect the 
smaller effect. Alternatively, it is possible that differential effects based on carrier status may be found if other 
studies had considered the role of the APOE ɛ4 allele, with obesity being protective in carriers yet harmful in 
noncarriers. 
Past studies have demonstrated that obesity, especially in mid-life, is related to cognitive decline later in life [9, 
14]. In our study, we did not find any effect of baseline BMI on conversion to MCI or dementia, and it was weight 
loss closer to the time of conversion rather than weight gain that predicted conversion. This discrepancy may be 
caused by weight loss masking the adverse effect of adiposity. Unintentional weight loss is common in old age, 
and typically signals the presence of pathologic processes that may contribute to the later development of AD or 
other morbidities [21, 39, 40]. 
We also found a differential impact of ΔBMI on AD risk based on carrier status, with the greatest effects of BMI 
change found in APOE ɛ4 carriers. Our finding that the relationship between BMI change and conversion to MCI 
or dementia is significant in APOE ɛ4 carriers but not noncarriers is consistent with past research that revealed a 
negative relationship between BMI and cognitive performance for carriers [31, 32]; however, these past studies 
did not examine conversion to MCI or dementia. Therefore, it appears that maintaining a healthy body weight is 
most important for those who are already genetically at risk for AD. For those studies that did not find a 
significant interaction between BMI and carrier status on risk of conversion [11, 33], several factors may be 
responsible for this difference. First, neither of these studies examined change in BMI over time as a predictor. 
Like these prior studies, the current research also found no relationship between BMI at baseline and carrier 
status on risk of conversion, suggesting that declines in BMI over time rather than BMI measures taken at a 
single timepoint are more predictive of conversion for carriers. Second, these studies measured BMI during 
midlife, whereas the present study examined BMI throughout late life, indicating that this relationship may be 
dependent on age. Finally, BMI was categorized into two [33] or three [11] groups in these previous studies 
which reduces power, whereas we examined BMI as a continuous predictor in the current study. For the one 
study that found the APOE ɛ4 allele did not moderate the relationship between weight loss over time and AD, 
this could be due to only men being included in the sample, as past research has found that the association 
between weight loss and the APOE ɛ4 allele was only present in women with dementia [41]. 
Not surprisingly, older age and the APOE ɛ4 allele were both significant predictors of conversion to MCI or 
dementia, which are two of the most well-established risk factors for AD [42, 43]. More interesting, however, 
was our finding that race significantly predicted conversion, with white participants being nearly twice as likely 
to convert than their nonwhite counterparts. This finding is inconsistent with past research suggesting that older 
African Americans and Hispanics are significantly more likely than older whites to develop AD or other 
dementias [43, 44]. However, white (versus nonwhite) race was associated with increased risk of conversion to 
MCI in other studies utilizing data from the NACC database, suggesting that this finding is unique to this 
particular sample [20]. To investigate the contribution of race further, the interaction between race and 
conversion to MCI or dementia on BMI (baseline and five-year change) and other demographic variables was 
examined. However, due to small sample sizes in the nonwhite, converter group leading to significant 
heterogeneity of variance, these results were not reported. Future research should examine this relationship in 
a larger group of minority individuals while also considering other factors that may account for significant 
changes in BMI. Lastly, education was not a significant predictor of conversion. While many studies have 
identified lower education as a risk factor for MCI or dementia [45–47], others have found no relationship [48, 
49]. The association between education and dementia appears to be strongest for those with little to no 
education and could be influenced by diagnostic biases, whereby those with the lowest levels of education 
perform worse on cognitive tests of dementia despite no differences in functional impairment [49]. Our overall 
sample (mean age = 72.1) had 16.1 (SD = 3.0) total mean years of education, which is much higher than the 
United States national average of 12.8 years for older adults aged 70–74 years according to 2010 data [50]. 
Thus, an effect of education may have been harder to detect due to the highly educated nature of this sample. 
Finally, a weak association between sex and conversion was found, whereby men were more likely to convert to 
MCI or dementia over the five-year observation period. It is unclear whether more men converted to MCI due to 
vascular reasons or due to frank AD. Although the literature has consistently identified higher incidence of 
dementia in women [51–53], sex differences typically do not emerge until after age 80 [54], and incident MCI 
has been shown to be higher in men than in women [55]. Our sample consisted primarily of converters to MCI 
and was restricted to participants aged 65 to 80, thus explaining the observed sex differences. 
The strengths of our study include the size of our overall sample and careful follow-up and characterization of 
the sample over five years. However, this study still has some limitations. First, the number of nonwhite 
individuals who converted was very low (N = 28), limiting the interpretability of our results due to significant 
heterogeneity of variance. Larger samples are needed in order to obtain the power needed for a significant 
effect. As noted earlier, the normal healthy controls recruited by the ADRCs were more highly educated than the 
general population, thus limiting the generalizability of our findings. In addition, many of our significant findings 
were tempered by small effect sizes. We also did not have any data on the causes of weight loss/gain in our 
sample, and this information would be helpful to determine whether unintentional weight loss due to 
pathological aging was responsible for the greater declines in BMI for converters relative to nonconverters. 
Because change in BMI and conversion to MCI or dementia were observed across the same five-year timespan, 
it remains unknown whether a decline in BMI is a risk factor or an early pathological sign of MCI/dementia. 
Lastly, BMI has been criticized for being a crude measure of body composition, but studies have shown that it 
does correlate well with dual-energy X-ray absorptiometry (DEXA), which has been considered the gold standard 
measure of body composition [56–58]. Flegal et al. (2009) compared BMI with other anthropometric measures 
and DEXA in healthy older adults in the same age range as our sample. They found that BMI correlated highly 
with other anthropometric measures such as waist circumference (Men: r = 0.93; Women: r = 0.88) and waist-
stature ratio (Men: r = 0.93; Women: r = 0.89) and also had a reasonably strong correlation with DEXA 
(Men: r = 0.738; Women: r = 0.763) [56]. Thus, we feel justified in using BMI within this age group. 
Nevertheless, our findings have some important implications for those at genetic risk for AD. This study 
demonstrated using a large, longitudinal cohort that experiencing a loss of BMI in old age increases one’s risk of 
conversion for APOE ɛ4 carriers. The specificity of these relationships among ɛ4 carriers suggest the possibility of 
concurrent changes in cognition and metabolism in those who convert to MCI or dementia. The precise 
mechanisms driving these associations are not fully understood but may reflect dysregulated brain lipid and 
glucose metabolism and reduced availability of fat from adipose tissue as a brain energy substrate during weight 
loss [36]. These effects may also be compounded by the combined impacts of decreased cellular cholesterol 
transport, increased neuro-inflammation, increased blood-brain barrier permeability, and amyloid-beta 
aggregation that are associated with the APOE ɛ4 allele [35]. Further research examining mechanisms that 
underly the relationships between BMI, APOE ɛ4, and conversion to MCI or dementia could elucidate whether 
BMI is a causal factor or an indicator of conversion. 
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